Clinical trials
Phase 1/2 Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 31 |
| Unknown status | 14 |
| Completed | 13 |
| Terminated | 8 |
| Active, not recruiting | 6 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenzhen Geno-Immune Medical Institute | 6 |
| Capital Medical University | 5 |
| First Affiliated Hospital of Zhejiang University | 3 |
| LaNova Medicines Limited | 3 |
| Peking Union Medical College Hospital | 3 |
| Shanghai EpimAb Biotherapeutics Co., Ltd. | 3 |
| Shenzhen University General Hospital | 3 |
| Essen Biotech | 2 |
| First Affiliated Hospital of Fujian Medical University | 2 |
| Peking University Cancer Hospital & Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 79 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 9 |
| Breast Neoplasms | 7 |
| Neoplasm Metastasis | 7 |
| Lung Neoplasms | 6 |
| Ovarian Neoplasms | 6 |
| Endometrial Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Gastrointestinal Neoplasms | 4 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.